Use of linezolid to treat MRSP bacteremia and discospondylitis in a dog

Journal of the American Animal Hospital Association

Volumn 50, Issue 1, 2014, Pages 53-58

  Foster, Jonathan D ^a,b   Trepanier, Lauren A ^a   Ginn, Jennifer A ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Wheat Ridge Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ANIMAL; CASE REPORT; DOG; DOG DISEASES; FEVER; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; SPONDYLITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; VERTEBRA; VETERINARY;

ACETAMIDES; ANIMALS; ANTI-INFECTIVE AGENTS; DOG DISEASES; DOGS; FEVER; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; SPONDYLITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; THORACIC VERTEBRAE;

EID: 84891893282     PISSN: 05872871     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/JAAHA-MS-5947     Document Type: Article

References (22)

1. Papich ME, Riviere JE. Chloramphenicol and derivatives, macrolides, lincosamides, and miscellaneous antibiotics. In: Riviere JE, Papich ME, eds. Veterinary pharmacology and therapeutics. 9th ed. Ames (IA): Wiley-Blackwell; 2009;971.
2. Linden PK. Treatment options for vancomycin-resistant enterococcal infections. Drugs 2002;62(3):425-41.
3. Cockerill F. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Wayne (PA): Clinical and Laboratory Standards Institute; 2011.
4. Oleson FB Jr, Berman CL, Kirkpatrick JB, et al. Once-daily dosing in dogs optimizes daptomycin safety. Antimicrob Agents Chemother 2000;44(11):2948-53.
5. Slatter JG, Adams LA, Bush EC, et al. Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica 2002;32(10):907-24.
6. Pfizer Inc. Zyvox prescribing information. New York; 2010. Available from http://labeling.pfizer.com/showlabeling.aspx?id=649. Accessed October 6, 2013.
7. Shamir MH, Tavor N, Aizenberg T. Radiographic findings during recovery from discospondylitis. Vet Radiol Ultrasound 2001;42(6): 496-503.
8. Schwartz M, Boettcher IC, Kramer S, et al. Two dogs with iatrogenic discospondylitis caused by meticillin-resistant Staphylococcus aureus. J Small Anim Pract 2009;50(4):201-5.
9. NienhoffU, Kadlec K, Chaberny IF, et al. Methicillin-resistant Staphylococcus pseudintermedius among dogs admitted to a small animal hospital. Vet Microbiol 2011;150(1-2):191-7.
10. Al-Nammari SS, Lucas JD, Lam KS. Hematogenous methicillinresistant Staphylococcus aureus spondylodiscitis. Spine 2007;32(22): 2480-6.
11. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology 1985;157(1):157-66.
12. Cottle L, Riordan T. Infectious spondylodiscitis. J Infect 2008;56(6): 401-12.
13. Fischer A, Mahaffey MB, Oliver JE. Fluoroscopically guided percutaneous disk aspiration in 10 dogs with diskospondylitis. J Vet Intern Med 1997;11(5):284-7.
14. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother 2010;65(suppl 3):iii11-24.
15. Burkert BA, Kerwin SC, Hosgood GL, et al. Signalment and clinical features of diskospondylitis in dogs: 513 cases (1980-2001). J AmVet Med Assoc 2005;227(2):268-75.
16. Hurov L, Troy G, Turnwald G. Diskospondylitis in the dog: 27 cases. J Am Vet Med Assoc 1978;173(3):275-81.
17. Lin AH, Murray RW, Vidmar TJ, et al. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother 1997;41(10):2127-31.
18. Stein GE, Wells EM. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Curr Med Res Opin 2010;26(3):571-88.
19. Krzysztofiak A, Pagnotta G, Lancella L, et al. Linezolid therapy for pediatric thoracic spondylodiscitis due to Staphylococcus aureus sepsis. Int J Infect Dis 2010;14(suppl 3):e205-7.
20. Rayner CR, Forrest A, Meagher AK, et al. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet 2003;42(15):1411-23.
21. Morley PS, Apley MD, Besser TE, et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 2005;19(4):617-29.
22. Gage ED. Treatment of discospondylitis in the dog. J Am Vet Med Assoc 1975;166(12):1164-9.